Advanced search
Publication Cover
Cell Cycle Volume 13, 2014 - Issue 3
Submit an article Journal homepage
2,478
Views
61
CrossRef citations to date
0
Altmetric
Extra Views

Reconciliation of classification systems defining molecular subtypes of colorectal cancer

Interrelationships and clinical implications

Anguraj Sadanandam Swiss Institute of Bioinformatics; Lausanne, Switzerland; Swiss Institute for Experimental Cancer Research; Swiss Federal Institute of Technology Lausanne (EPFL); Lausanne, SwitzerlandCorrespondence[email protected] [email protected]
,
Xin Wang Cancer Research UK Cambridge Institute; University of Cambridge; Cambridge, UK
,
Felipe de Sousa E Melo Laboratory for Experimental Oncology and Radiobiology; Center for Experimental Molecular Medicine; Academic Medical Center (AMC); Amsterdam, The Netherlands
,
Joe W Gray Department of Biomedical Engineering; Oregon Health and Science University; Portland, OR USA
,
Louis Vermeulen Cancer Research UK Cambridge Institute; University of Cambridge; Cambridge, UK; Laboratory for Experimental Oncology and Radiobiology; Center for Experimental Molecular Medicine; Academic Medical Center (AMC); Amsterdam, The NetherlandsCorrespondence[email protected] [email protected]
,
Douglas Hanahan Swiss Institute for Experimental Cancer Research; Swiss Federal Institute of Technology Lausanne (EPFL); Lausanne, Switzerland
&
Jan Paul Medema Laboratory for Experimental Oncology and Radiobiology; Center for Experimental Molecular Medicine; Academic Medical Center (AMC); Amsterdam, The Netherlands
 show all
Pages 353-357 | Received 12 Dec 2013, Accepted 08 Jan 2014, Published online: 09 Jan 2014

References

  • De Sousa E Melo F, Wang X, Jansen M, Fessler E, Trinh A, de Rooij LP, de Jong JH, de Boer OJ, van Leersum R, Bijlsma MF, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med 2013; 19:614 - 8; http://dx.doi.org/10.1038/nm.3174; PMID: 23584090
  • Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, Ostos LC, Lannon WA, Grotzinger C, Del Rio M, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med 2013; 19:619 - 25; http://dx.doi.org/10.1038/nm.3175; PMID: 23584089
  • Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138:2073 - 87, e3; http://dx.doi.org/10.1053/j.gastro.2009.12.064; PMID: 20420947
  • de Sousa E Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, Tuynman JB, Prasetyanti PR, Fessler E, van den Bergh SP, et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011; 9:476 - 85; http://dx.doi.org/10.1016/j.stem.2011.10.008; PMID: 22056143
  • Merlos-Suárez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, Rossell D, Sevillano M, Hernando-Momblona X, da Silva-Diz V, Muñoz P, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011; 8:511 - 24; http://dx.doi.org/10.1016/j.stem.2011.02.020; PMID: 21419747
  • Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487:330 - 7; http://dx.doi.org/10.1038/nature11252; PMID: 22810696
  • Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK, et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol 2007; 25:3230 - 7; http://dx.doi.org/10.1200/JCO.2006.10.5437; PMID: 17664471
  • Sotiriou C, Piccart MJ. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?. Nat Rev Cancer 2007; 7:545 - 53; http://dx.doi.org/10.1038/nrc2173; PMID: 17585334
  • De Roock W, Piessevaux H, De Schutter J, Janssens M, De Hertogh G, Personeni N, Biesmans B, Van Laethem JL, Peeters M, Humblet Y, et al. KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol 2008; 19:508 - 15; http://dx.doi.org/10.1093/annonc/mdm496; PMID: 17998284
  • McCall MN, Bolstad BM, Irizarry RA. Frozen robust multiarray analysis (fRMA). Biostatistics 2010; 11:242 - 53; http://dx.doi.org/10.1093/biostatistics/kxp059; PMID: 20097884
  • Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8:118 - 27; http://dx.doi.org/10.1093/biostatistics/kxj037; PMID: 16632515
  • Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5:R80.1-16; http://dx.doi.org/10.1186/gb-2004-5-10-r80; PMID: 15461798

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.